For the current REF see the REF 2021 website REF 2021 logo

Output details

1 - Clinical Medicine

University of Cambridge

Return to search Previous output Next output
Output 86 of 750 in the submission
Article title

AT9283, a potent inhibitor of the Aurora kinases and Jak2, has therapeutic potential in myeloproliferative disorders.

Type
D - Journal article
Title of journal
Br J Haematol
Article number
-
Volume number
150
Issue number
1
First page of article
46
ISSN of journal
1365-2141
Year of publication
2010
Number of additional authors
12
Additional information
-
Interdisciplinary
-
Cross-referral requested
-
Research group
None
Citation count
23
Proposed double-weighted
No
Double-weighted statement
-
Reserve for a double-weighted output
No
Non-English
No
English abstract
-